BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1330312)

  • 1. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J; Rojas A; de la Rosa M; Amador JM; Expósito J; Esquivias J
    Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
    Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
    Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of slides for Epstein-Barr virus diagnosis by indirect immunofluorescence].
    Pérez GR; Taborda MA; Toffi A; Palonsky M; Pagotto M; Gardiol DN; Giri AA
    Medicina (B Aires); 2005; 65(4):315-20. PubMed ID: 16193709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on antibodies against EBV in sera of patients with rheumatoid arthritis].
    Zhang X; Li B; Liu Y; Jiang M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):8-12. PubMed ID: 12569633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP; Hilgers R; Skvaril F
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of a dot-blot technique for the detection of Epstein-Barr virus antibodies (IgG anti-viral capsid antigen)].
    Bouillet L; Cattoen C; Keilani A; Chatelain C; Mazars E
    Ann Biol Clin (Paris); 1998; 56(1):79-83. PubMed ID: 9754226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
    Ternák G; Szúcs G; Uj M
    Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.